Black Diamond Therapeutics BDTX Cash Flow Statement (2018-2026)

NASDAQ BDTX
$1.96 -0.14 (-6.67%)
As of: Sep 10, 2026 · 3:59 PM EDT
Reported Financials

Black Diamond Therapeutics Quarterly Cash Flow Statement

Periods 31 quarters
Latest Jun 2026

Black Diamond Therapeutics reported cash from operations of -$7.97M and free cash flow of -$8.22M for the quarter ended Jun 2026, up 13.0% year over year. This cash flow statement covers 31 quarters of results from Dec 2018 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow Statement Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income
-34.59M-25.49M-25.27M-22.79M-21.56M-21.18M-20.94M-19.49M-23.57M-20.53M-19.61M-21.67M-17.61M-17.71M55.12M-12.30M-9.81M-16.43M-10.24M-11.13M
Share-based CompensationStock Comp.
3.01M3.38M3.38M3.25M2.66M2.91M2.67M2.65M2.75M1.54M1.71M5.29M1.99M1.64M1.70M1.78M1.74M1.41M1.45M1.51M
Cash from OperationsCash from Ops.
-26.48M-24.05M-28.60M-18.07M-16.48M-21.94M-20.03M-14.37M-18.36M-13.96M-21.20M-14.73M-11.32M-15.05M53.41M-9.16M-7.85M-6.79M-10.23M-7.97M
Depreciation, Depletion & Amortization
Amortizatization of IntangiblesAmort. of Intangibles
Change in Working Capital
Change in Account PayablesChange Payables
0.63M-0.69M-2.22M0.34M3.54M-3.88M1.17M-0.34M-1.86M1.63M-1.13M-0.43M1.21M2.04M-1.38M-1.86M0.20M-0.40M2.39M-1.56M
Change in Accured ExpensesChange Accured Exp.
3.34M-1.98M-1.96M0.12M-2.09M-1.94M-3.58M1.36M3.21M2.95M-1.64M2.00M1.15M-2.26M-2.35M1.81M-1.46M0.58M-3.59M2.87M
Investing Activities
Capital ExpendituresCapex
1.18M0.33M0.01M0.19M-0.01M0.03M0.34M-0.04M-0.04M-0.04M-0.04M-0.04M-0.04M-0.04M0.26M
Sales of Property, Plant and EquipmentPP&E (Sale)
0.01M0.04M0.05M0.01M0.01M0.01M0.00M0.00M
Change in Acquisitions & DivestmentsChange Acquisitions
39.19M48.50M37.24M20.00M30.45M26.00M24.81M17.08M8.25M28.04M38.50M40.50M30.00M30.75M32.00M30.58M23.50M33.01M19.50M15.00M
Cash from Investing ActivitiesCash from Investing
35.70M43.24M16.73M19.81M14.51M2.32M24.81M17.18M-37.88M12.25M-13.73M0.74M2.19M27.77M8.55M-59.15M8.59M-2.89M19.50M-3.12M
Financing Activities
Other financing activitiesOther financing
0.06M0.15M0.05M-0.03M0.05M0.08M-0.05M0.15M0.36M0.25M0.29M0.03M
Cash from Financing ActivitiesCash from Financing
0.06M0.15M0.05M-0.03M0.05M71.93M-0.05M4.13M21.38M-0.25M0.29M0.03M-0.12M0.13M-0.20M-0.18M0.22M
Change in Capital Stock
Net Equity Issued and RepurchasedNet Equity Issued
71.85M3.98M21.01M-0.50M
Additional items
Change in Cash
9.28M19.20M-11.72M1.74M-1.92M-19.64M4.83M2.81M15.68M-1.75M-30.80M7.39M-9.38M13.01M61.99M-68.43M0.87M-9.87M9.08M-10.88M
Free Cash FlowFCF
-27.66M-24.38M-28.61M-18.26M-16.47M-21.94M-20.03M-14.37M-18.39M-13.96M-21.20M-15.06M-11.28M-15.01M53.45M-9.12M-7.81M-6.74M-10.19M-8.22M
Net Cash FlowNCF
9.28M19.20M-11.72M1.74M-1.92M-19.64M4.83M2.81M15.68M-1.75M-30.80M7.39M-9.38M13.01M61.99M-68.43M0.87M-9.87M9.08M-10.88M